CLINICAL TRIAL

Phase I Study of the Safety and Adjunctive Effects of Psilocybin in Adults With Opioid Use Disorder Maintained on a Buprenorphine/Naloxone Formulation

An abstract is available from the original source but is not redistributed by this tracker. Read the source record.

Open source BibTeX RIS

Bibliographic context

Journal: ClinicalTrials.gov
Date: 2026-07-07
Source: ClinicalTrials.gov
DOI: Unavailable
PubMed: Unavailable

Authors

University of Wisconsin Madison

Watch author

Derived topics and classifications

psilocybin Addiction Chronic Pain Clinical Trial Observational Study Safety Adverse Events Clinical Trial

Citation graph

0 referenced DOIs found in stored source metadata. 0 indexed papers cite this DOI.

Open citation network

Related papers

Cancer at the Dinner Table: Experiences of Psilocybin-Assisted Psychotherapy for the Treatment of Cancer-Related Psychological DistressWestern CEDAR (Western Washington University) · 2018-01-01 Narrative therapy-assisted psilocybin use for treatment of depressionSeattle Pacific University Research Conference · 2017-01-01